02.09.2022
Prevention
$4,025,335.00
36 months
Very Early Onset Inflammatory Bowel Disease (VEOIBD): Precision Molecular Diagnoses to Targeted Therapies: Boston Studies
This grant proposes to identify and characterize novel genetic causes of VEOIBD that may lead to the development of innovative tailored therapeutic strategies for patients.